Drugs that prolong life? They just might happen, predicted a U.S. expert during a JGH lecture. The key is to delay the onset of disease by using drugs to mimic the illness-resisting capabilities that occur naturally in the bodies of centenarians.
To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.